BackCovetrus Overview

Covetrus Profit Margin

Valuation check: CVET's profit margin is -0.28%, below the Healthcare sector average of 13.39%.

Get informed when a big investor buys or sells

+ Follow

Quarterly Profit Margin

-0.33%
↑ 87.39% YoY

As of Jun 2022

Annual Profit Margin (TTM)

-0.28%
↑ 85.24% YoY

Trailing 12 months ending Jun 2022

Average Profit Margin (Comparison Companies)

Loading

Profit Margin History

Loading

Profit Margin Comparison

Loading

Annual Profit Margin Growth Rate (%)

Loading

Covetrus (CVET) FAQ

The latest profit margin for CVET is -0.28% as of June 2022. That compares with -1.89% in the prior-year period — up 85.2% year over year. That is below the Healthcare sector average of 13.39%. Investors often review this figure alongside Covetrus's historical trend and sector peers before judging valuation or financial health.

Over the past year, CVET's profit margin moved from -1.89% to -0.28% — a 85.2% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Covetrus's valuation or profitability profile.

Against Healthcare companies, CVET currently prints -0.28% for profit margin, while the sector average sits near 13.39%. That is roughly 102.1% below the sector mean. Large gaps often invite a closer look at Covetrus's growth, margins, and balance sheet.

Profit Margin shows how effectively Covetrus converts resources into returns. At -0.28%, CVET may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -1.89% in the prior-year period — up 85.2% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting CVET's profit margin (-0.28%), review year-over-year change from -1.89%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.